Shares of Elevance Health Inc. ELV rallied 1.02% to $396.88 Friday, on what proved to be an all-around favorable trading ...

Elevance Health Inc. closed 30.74% short of its 52-week high of $567.26, which the company reached on September 3rd.

U.S. health benefits company Elevance Health, Inc. ELV shares have declined 29.6% quarter to date, underperforming its industry and the S&P 500 Index. Closing at $366.48 on Thursday, near its 52 ...

For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.

Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results ...

In its fourth quarter 2024 investor letter, Artisan Select Equity Fund emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health benefits company ...

Despite a 29% drop in Elevance Health's stock, I maintain a strong ... Elevance has been down 29% while the S&P 500 has been up 10%. This decrease was mainly on the back of a guidance change ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Verily, an Alphabet (GOOG) (GOOGL) precision health company, has agreed to sell the company’s Granular insurance business to Elevance Health (ELV), reported Business Insider. Leverage the power ...

Elevance Health shares fell 21% in 2024 due ... the timing of transactions and other factors. The S&P 500 Index is an unmanaged capitalization-weighted index of the common stocks of 500 major ...